AXIM BIOTECHNOLOGIES, INC.
AXIM® Biotechnologies, Inc. is a vertically integrated research and development company focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic tests. AXIM has developed and commercialized two point-of-care ophthalmological diagnostic solutions focused on diagnosis of Dry Eye Disease. AXIM owns two of the five FDA Cleared Diagnostic tests for Dye Eye Disease.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
Allogene Therapeutics, Inc.
Allogene Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They have a fully integrated team dedicated to research, development, and cell manufacturing. Their goal is to deliver "off-the-shelf" CAR T cell candidates faster and more reliably.
Spyre Therapeutics, Inc.
Spyre Therapeutics is engineering next-generation antibodies for prolonged activity, focused on inflammatory bowel disease (IBD) and other immune-mediated diseases. They are developing monotherapies and combination therapies designed for uncompromising efficacy and convenience. Their pipeline targets validated mechanisms with the potential to treat several gastrointestinal and rheumatic conditions. The company is committed to improving the lives of patients through innovative treatment options.
Prime Medicine, Inc.
Prime Medicine is a biotechnology company focused on developing gene therapies using Prime Editing technology. They aim to cure genetic diseases by precisely editing DNA. Developed at the Broad Institute, Prime Editing has the potential to address a wide range of diseases and overcome limitations of existing gene editing approaches.